Results 41 to 50 of about 26,491 (207)

Effect of transcranial magnetic stimulation in combination with citalopram on patients with post-stroke depression

Frontiers in Human Neuroscience, 2022
BackgroundAmelioration of depression in patients with post-stroke depression (PSD) remains challenging.ObjectiveThe primary vision was to explore the effect of transcranial magnetic stimulation (TMS) in combination with citalopram on patients with PSD ...
Zhen Zhu, Hao-Xuan Zhu, Shao-Wei Jing, Xia-Zhen Li, Xiao-Yan Yang, Tu-Nan Luo, Shuai Ye, Xiao-Chun Ouyang, Wei-Wei Song   +8 more
doaj   +1 more source

Reprocessing Mass Spectra from Therapeutic Drug Monitoring to Unveil Proton Pump Inhibitor Use and Quantify Phenoconversion of Escitalopram Metabolism in CYP2C19‐Genotyped Patients

Clinical Pharmacology &Therapeutics, EarlyView.
Escitalopram is a frequently prescribed antidepressant drug. CYP2C19 genotype is a major determinant of escitalopram metabolism and treatment outcome. However, real‐life studies show a high degree of genotype–phenotype mismatch in escitalopram metabolism.
Kristine Hole, Birgit M. Wollmann, Julia Carolin Stingl, Espen Molden   +3 more
wiley   +1 more source

Population‐Stratified Distributions of Post‐Mortem Blood Drug Concentrations: An Epidemiological Framework for Contextual Interpretation

Drug Testing and Analysis, EarlyView.
Post‐mortem blood drug concentrations exhibit substantial overlap between deaths in which a drug was implicated and those in which it was not. Analysis of over 58,000 NPSUM cases demonstrates that demographic stratification does not resolve this uncertainty, reinforcing the need for contextual, evidence‐based interpretation rather than concentration ...
Thikra Algahtani, Kirsten L. Rock, Kathleen Rice‐Davies, Rebecca Lo, Benedict Morley, Stephen Morley, Caroline S. Copeland   +6 more
wiley   +1 more source

Anti-platelet effects of citalopram [PDF]

, 2014
Introduction Citalopram is a preferred medication used for the treatment of depression and belongs to a group known as selective serotonin reuptake inhibitors (SSRI).
Richter, Tomáš
core  

EFFICACY OF CITALOPRAM IN TREATMENT OF PATHOLOGICAL SKIN PICKING, A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED TRIAL [PDF]

Acta Medica Iranica, 2008
Various studies suggest that selective serotonin reuptake inhibitors (SSRIs) may be useful in treating pathological skin picking (PSP). This study sought to assess effectiveness of citalopram in comparison with placebo in treating PSP.
M Arbabi, V Farnia, K Balighi, M Mohammadi, A Nejati-Safa, k Yazdchi, B Golestan, F Darvish   +7 more
doaj   +1 more source

Improving the Sensitivity in Chiral Analysis by Capillary Electrophoresis

ELECTROPHORESIS, EarlyView.
Most recent advances for the enhancement of sensitivity in capillary electrophoresis, including off‐line and in‐capillary preconcentration techniques and their combinations, and the use of alternative detection systems to UV–Vis spectrophotometric absorption.
María Castro‐Puyana, Sandra Salido‐Fortuna, María Luisa Marina   +2 more
wiley   +1 more source

First time, low dose citalopram use-related serotonin syndrome

, 2007
Citalopram is a very potent and highly selective inhibitor of neuronal serotonin (5-hydroxytryptamine, or 5-HT). Serotonin syndrome is a rarely observed side-effect of citalopram use.
TÜREDİ, SÜLEYMAN, Eraydin, Ismet, Kalkan, Asim, GÜNDÜZ, ABDÜLKADİR, Hos, Ulku   +4 more
core   +1 more source

Mechanisms of platelet inhibition by the selective serotonin reuptake inhibitor citalopram [PDF]

, 2018
Background: Selective serotonin reuptake inhibitor (SSRI) antidepressants prevent serotonin (5-HT) uptake by the serotonin transporter (SERT). Since blood platelets express SERT, SSRIs may modify platelet function and the risk of cardiovascular disease ...

core   +2 more sources

Comparative assessment of antidepressant-related behaviors of citalopram, crocin, and their combination in non-acute restraint stress and acute restraint stress mice

IBRO Neuroscience Reports
Many studies demonstrated the role of citalopram (the bromohydrate of citalopram, which inhibits 5-HT reuptake) and crocin (a carotenoid chemical compound, antioxidant, antidepressant) in the modulation of depression-related behaviors.
Maryam Parhizkari, Fatemeh Khakpai, Mohammad-Reza Zarrindast   +2 more
doaj   +1 more source

The effect of citalopram treatment on amyloid-β precursor protein processing and oxidative stress in human hNSC-derived neurons

Translational Psychiatry, 2022
Selective Serotonin Reuptake Inhibitors (SSRIs) may hold therapeutic benefits for people with Alzheimer’s disease (AD). SSRIs may perturb AD progression, or the conversion from MCI to AD, via increased neurogenesis, reduced oxidative stress and/or ...
R. J. Elsworthy, J. A. Crowe, M. C. King, C. Dunleavy, E. Fisher, A. Ludlam, H. R. Parri, E. J. Hill, S. Aldred   +8 more
doaj   +1 more source